VEGFA and diabetic macular edema: For example, for diabetic macular edema (DME) patients, clinicians can select the most suitable anti-VEGF drug by considering ML-predicted indicators and drug prices, The improved model can be better applied to medical institutions in underdeveloped areas and primary hospitals, and enhance the diagnostic efficiency and accuracy of clinicians, as well as help reduce the economic burden on patients.